Navigation Links
Heart drug cuts prostate cancer risk; holds potential for therapeutic use
Date:4/2/2011

Johns Hopkins scientists and their colleagues paired laboratory and epidemiologic data to find that men using the cardiac drug, digoxin, had a 24 percent lower risk for prostate cancer. The scientists say further research about the discovery may lead to use of the drug, or new ones that work the same way, to treat the cancer.

Digoxin, made from the foxglove plant, has been used for centuries in folk medicine and for decades to treat congestive heart failure and heart rhythm abnormalities. It also emerged as a leading candidate among 3,000 drugs screened by the Johns Hopkins team for the drugs' ability to curb prostate cancer cell growth, according to the investigators, who published their findings in the April 3 issue of Cancer Discovery.

Additional research, by the team, in a cohort of more than 47,000 men revealed that those who took digoxin for heart disease had a significantly lower risk of prostate cancer. The scientists cautioned, however, that their work does not prove digoxin prevents prostate cancer nor are they suggesting the drug be used to prevent the disease. "This is not a drug you'd give to healthy people," says Elizabeth Platz, Sc.D., M.P.H., professor of epidemiology, oncology, and urology at the Johns Hopkins Bloomberg School of Public Health. Serious side effects include male breast enlargement and heart rhythm irregularities, and the drug commonly causes nausea, vomiting and headache.

In the first stage of research, Johns Hopkins assistant professor Srinivasan Yegnasubramanian, M.D., Ph.D, Kimmel Cancer Center director and professor William G. Nelson, M.D., Ph.D., and professor Jun Liu, Ph.D., identified 38 compounds already FDA-approved or with a history of medical use out of a database of more than 3,000. The 38 candidate drugs reduced prostate cancer cell growth in the laboratory by at least 50 percent. They did not include known chemotherapy drugs among the 38.

Nelson and Yegnasubramanian
'/>"/>

Contact: Vanessa Wasta
wasta@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Laughter Not Only Feels Good, Its Good for the Heart
2. Study suggests a relationship between migraine headaches in children and a common heart defect
3. Risks May Rise With Need for Nursing Care After Heart Failure
4. Cost of heart drugs makes patients skip pills, putting themselves at risk
5. Conflicts of Interest Cloud Heart Treatment Guidelines: Study
6. Healthy Lifestyles Could Halve Cases of Dangerous Irregular Heartbeat
7. Dark Chocolate May Harbor Benefits for the Heart
8. Americans Exposure to Mercury From Fish Wont Harm Hearts: Study
9. Outcomes improved by longer delays between heart attacks and elective surgeries
10. Study: Infrequent Sex Can Raise Risk of Heart Attack, Death
11. Do all student athletes need heart screenings?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... ... Down is a reliable source for last minute tickets for The Rolling Stones at ... North America in conjunction with their 2015 “Zip Code Tour.” , The Stones have been ... their twenties. Some of the most beloved songs that this iconic group has performed ...
(Date:6/30/2015)... Minn. (PRWEB) , ... June 30, 2015 , ... The ... million in funding for 24 projects across the state. The projects improve community health ... range from $25,000 to $100,000 and many are renewable for a second year in ...
(Date:6/30/2015)... Monica, CA (PRWEB) , ... June 30, 2015 ... ... of its new YouTube video, “Fireside Convalescent Care Center.” The video informs community ... the video after continually seeing the need for those seeking care to be ...
(Date:6/30/2015)... ... June 30, 2015 , ... Today, Grand Terrace Health ... Health Care Center.” Each year, Medicare ranks care centers around the country in ... for their needs. Grand Terrace prides itself on quality in each of Medicare’s ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... that they have been awarded the exclusive billing agreements with Jackson Radiology Associates ... billing services encompassing their proprietary suite of billing process software functionality called Experience ...
Breaking Medicine News(10 mins):Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:Fireside Convalescent Hospital Proves Itself as a Leading Care Center in New Video 2Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2
... has taken over as the Director General of Army's Medical ... Medical College, Nagpur he was commissioned into the Army Medical ... from Pune University in 1977, he completed training in Radiation ... MD from Bombay University. ,A pioneer in ...
... of the journal SLEEP finds that people with obstructive ... disease.// ,The study attributes the increased link ... a rising prevalence. Results suggest that OSA plays a ... hypertension. ,"There is abundant physiologic evidence ...
... fragrant, blooming trees and lush green grasses – and sneezing ... ,Hay fever, or seasonal allergic rhinitis, affects an ... and watery eyes, runny nose and a burning or itchy ... commonly caused by tree and grass pollens, and depends on ...
... green tea has long been touted for its healthful ... found// that a component of green tea, combined with ... spread of human prostate cancer. ,In the ... University of Wisconsin-Madison demonstrate that low doses of the ...
... study has proven false established medical practice that an antiretroviral ... safe to use// on its own in patients co-infected with ... cross-resistance to other antiviral drugs used to treat the AIDS ... different from any other that has been shown to be ...
... negative social reactions may increase the psychological effects of ... at Chicago study. ,The study, published in ... negative reactions that victims experience when seeking support could ... symptoms. ,The findings suggest further public education ...
Cached Medicine News:Health News:Sleep Well, Have a Healthy Heart ! 2Health News:Weather Forecasts Spring Pollen Allergy Severity 2Health News:Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer 2Health News:Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer 3Health News:Widely Used Hepatitis B Drug Spurs HIV Drug Resistance 2Health News:Widely Used Hepatitis B Drug Spurs HIV Drug Resistance 3Health News:Study Examines Negative Reactions to Sexual Assault Victims 2
(Date:6/30/2015)... A new analysis and infographic released ... Hepatitis C medications could range from hundreds of millions of ... Hepatitis C receive treatment through state programs. The analysis, which ... on public programs, comes at a time when state and ... Gilead Sciences, Harvoni and Sovaldi. ...
(Date:6/30/2015)...  Inari Medical, Inc. announced today that it has ... The financing was led by members of the board ... Venture Partners.  The round also included participation by several ... pleased to complete this financing with the support of ... who joined in February 2015 as President and Chief ...
(Date:6/30/2015)... 30, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical Company focused on the development of oral drug ... been screened in the Company,s Phase IIb trial of ... will be performed under the active Investigational New Drug ... Drug Administration (FDA). The Phase IIb study ...
Breaking Medicine Technology:New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3
... Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: ... updated the progress of its Phase II,clinical ... cancer patients who are unable to tolerate ... trial for first-line,treatment of biliary cancer patients. ...
... Late-breaking Phase III,clinical trial data presented today ... Haemostasis (ISTH) Congress demonstrate,that once-daily rivaroxaban achieved ... (VTE) in patients undergoing,knee replacement surgery in ... of care. Patients in the RECORD3,(REgulation of ...
Cached Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
... Stainless steel spiral reinforced. X-ray opaque . Low ... Flange: The flange can be adjusted along the ... cervical soft tissue. The lock ring is turned ... the shaft. Maximum Patient Comfort: The tube is ...
... Per-fit™ tubes are a dual ... of the disposable inner cannula ... provided in the procedural tray. ... tubes are available separately. Per-fit™ ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
Thermosensitivity of material allows tube to conform to patients anatomy for maximum patient comfort....
Medicine Products: